continued One company source told the Syracuse Post Standard that the restructuring will include 45 involuntary layoffs and 75 voluntary buyouts at the Skaneateles headquarters.
Welch Allyn did not respond to calls for confirmation of these numbers.
The company said it will offer all affected employees a “generous” separation package, including outplacement assistance from one of the world's leading outplacement firms. It also will offer a “unique” continuing education assistance benefit that will reimburse up to $4,000 of the cost of education for the successful completion of coursework through an accredited institution and/or for the successful achievement of a professional certification designation offered by a recognized organization. This benefit will be available to these employees for up to 12 months after separation.
“This restructuring plan will help us maintain competitive levels of investment in new products and technologies that are necessary to meet the changing needs of the global healthcare environment,” Meyer said.
As part of the restructuring, the company will close its Beaverton, Ore., manufacturing plant — cutting 160 jobs — and ship production to Skaneateles, where employees will be retrained to handle the new jobs. Some of the Oregon employees will be offered jobs in Skaneateles. Some of the work from the Skaneateles plant, such as thermometer probe cover, lamp and some blood pressure cuff manufacturing operations, will be moved to the company's Tijuana plant.
“Our plan is well thought out and tied to the rapidly changing healthcare market, and in keeping with our history of making sure we treat our employees fairly and with the highest level of respect. We are confident we will emerge from this restructuring stronger than ever,” Meyer said.